Newsroom | 4292 results

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on November 28, 2025. One individual was hired by Adicet in November 2025 and granted new hire non-qualified stock options to purchase 20,600 shares of Adicet’s common stock with an exercise price of $0.65 per share, the closing price of...

DUBLIN--(BUSINESS WIRE)--The "Graft Versus Host Disease (GvHD) Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Graft Versus Host Disease (GvHD) Treatment was valued at US$2.9 Billion in 2024 and is projected to reach US$4.5 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisio...

IRVINE, Calif.--(BUSINESS WIRE)--Immunis, Inc., a clinical-stage biotech pioneering multi-active stem cell-derived biologics for age and disease-related immune dysregulation, today announced it has been named one of the Top 50 Healthcare Technology Companies of 2025 by The Healthcare Technology Report, recognizing notable advances in next-generation therapeutics, care delivery and clinical insights. The recognition follows the company’s recent publication in Obesity showing body fat loss and in...

SAN FRANCISCO--(BUSINESS WIRE)--Susannah Cantrell, PhD, has joined Ossium Health's leadership team as Chief Commercial Officer (CCO)....

DUBLIN, Ireland--(BUSINESS WIRE)--Prothena Announces Poster Presentation on its TDP-43 CYTOPE® Program at Neuroscience 2025...

DUBLIN--(BUSINESS WIRE)--The "Cell and Gene Therapy Business Outlook" report has been added to ResearchAndMarkets.com's offering. The Twice-Monthly Publication Cell and Gene Therapy Business Outlook will offer the following: Market Sizing and Forecasting of CAGT Markets: Each issue sizes up the market opportunity and projects the future revenues for a given therapeutic segment. Keeping an Eye on Financing: With billions of investment dollars announced each year, Cell and Gene Therapy Business O...

BERLIN--(BUSINESS WIRE)--Lors du sommet franco-allemand sur la souveraineté numérique qui s’est tenu aujourd’hui à Berlin, Owkin, en collaboration avec ses partenaires universitaires de premier plan Gustave Roussy (France) et Charité Comprehensive Cancer Center (Allemagne), a annoncé une initiative historique visant à construire la première infrastructure agentique paneuropéenne pour rendre les données biologiques compatibles avec l’IA, une étape clé vers la superintelligence biologique. Le pro...

BERLIN--(BUSINESS WIRE)--Auf dem heutigen deutsch-französischen Gipfeltreffen zur digitalen Souveränität in Berlin hat Owkin gemeinsam mit führenden akademischen Partnern, Gustave Roussy (Frankreich) und dem Charité Comprehensive Cancer Center (Deutschland), eine wegweisende Initiative zum Aufbau der ersten paneuropäischen Infrastruktur angekündigt, die biologische Daten für KI nutzbar machen soll. Dies ist ein wichtiger Schritt auf dem Weg zur biologischen Superintelligenz. Das Projekt zielt d...

BERLÍN--(BUSINESS WIRE)--En la Cumbre de Soberanía Digital Francoalemana del día de hoy en Berlín, Owkin, junto con los socios académicos líderes Gustave Roussy (Francia) y Charité Comprehensive Cancer Center (Alemania), anunció una iniciativa pionera para construir la primera infraestructura agéntica paneuropea con el objetivo de que los datos biológicos estén preparados para IA, como paso clave hacia una superinteligencia biológica. El proyecto busca desarrollar e implementar métodos de IA mo...

BERLIJN--(BUSINESS WIRE)--Tijdens de Frans-Duitse top over digitale soevereiniteit die vandaag in Berlijn plaatsvindt, heeft Owkin samen met vooraanstaande academische partners Gustave Roussy (Frankrijk) en Charité Comprehensive Cancer Center (Duitsland) een baanbrekend initiatief aangekondigd: het ontwikkelen van de eerste pan-Europese agentic infrastructuur waarbij biologische gegevens aan AI worden aangepast. Dit is een belangrijke stap op weg naar biologische superintelligentie. Het project...